Do you want to read an article? Please log in or register.
Hormone replacement therapy and risk of severe asthma exacerbation in peri-menopausal and post-menopausal women: 17-year national cohort study
Asthma
RECOMMENDED
Related content
RECOMMENDED
Asthma
Incidence, risk factors and re-exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Pediatr Allergy Immunol.
Engelkes M, Baan EJ, de Ridder MAJ, Svensson E, Prieto-Alhambra D, Lapi F, Giaquinto C, Picelli G, Boudiaf N, Albers F, Evitt LA, Cockle S, Bradford E, Van Dyke MK, Suruki R, Rijnbeek P, Sturkenboom MCJM, Janssens HM, Verhamme KMC
doi: 10.1111/pai.13237.
Asthma
Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study
Lancet Respir Med.
O'Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zheng J, Gustafson P, Lamarca R, Puu M, Keen C, Alagappan VKT, Reddel HK
doi: 10.1016/S2213-2600(20)30416-1.
RECOMMENDED
Asthma
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Busse WW, Wenzel SE, Casale TB, FitzGerald JM, Rice MS, Daizadeh N, Deniz Y, Patel N, Harel S, Rowe PJ, Graham NMH, O'Riordan T, Pavord ID
doi: 10.1016/S2213-2600(21)00124-7
Asthma
A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels
Respir Med.
Haughney J, Morice A, Blyth KG, Lee AJ, Coutts A, McKnight E, Pavord I
doi: 10.1016/j.rmed.2017.12.001.
RECOMMENDED
Asthma
Effect of asthma exacerbation during pregnancy in women with asthma: A population-based cohort study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir J.
Abdullah K, Zhu J, Gershon A, Dell S, To T
doi: 10.1183/13993003.01335-2019.
RECOMMENDED
Further Publications
The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lancet Respir Med
McDowell PJ, Diver S, Yang F, Borg C, Busby J, Brown V, Shrimanker R, Cox C, Brightling CE, Chaudhuri R, Pavord ID, Heaney LG, Medical Research Council: Refractory Asthma Stratification Programme (RASP-UK Consortium).
doi: 10.1016/S2213-2600(21)00004-7
COMMENTED
Asthma
Hormone replacement therapy and development of new asthma
★ 3
Recommended and commented by
Dr Martin Frey, Faculty Member
Chest
Halvard Hansen ES, Aasbjerg K, Moeller AL, Gade EJ, Torp-Pedersen C, Backer V
doi: 10.1016/j.chest.2021.01.054
RECOMMENDED
Asthma
Sensitisation to staphylococcal enterotoxins and asthma severity: a longitudinal study in the EGEA cohort
Eur Respir J.
Sintobin I, Siroux V, Holtappels G, Pison C, Nadif R, Bousquet J, Bachert C
doi: 10.1183/13993003.00198-2019.
COPD
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Lancet Respir Med.
GBD 2015 Chronic Respiratory Disease Collaborators
doi: 10.1016/S2213-2600